Helicobacter pylori

+How to treat

In print

Helicobacter pylori

10 April 2024

By Cameron Schauer

Wednesday 10 April 2024, 12:45 AM

[Image: Fraser Williamson]

In recent years, rates of testing for Helicobacter pylori infection in New Zealand have increased considerably, with over 80 per cent of non-invasive tests performed in primary care. However, there are no consensus guidelines on its management. In this article, Cameron Schauer adds some background, context and clarity to this seemingly ubiquitous infection

This How to Treat has been endorsed by the RNZCGP and has been approved for up to 1 credit for continuing professional development purposes (1 credit , Educate small, BACK panel - grey

How to Treat

Infectious Disease

Gastroenterology

Oncology

Medicines and Therapies

References

McDonald AM, Sarfati D, Baker MG, Blakely T. Trends in Helicobacter pylori infection among Māori, Pacific, and European Birth cohorts in New Zealand. Helicobacter 2015;20(2):139–45.
Hsiang J, Selvaratnam S, Taylor S, et al. Increasing primary antibiotic resistance and ethnic differences in eradication rates of Helicobacter pylori infection in New Zealand – a new look at an old enemy. N Z Med J 2013;126(1384):64–76.
Jaakkimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. BMJ 1999;319(7216):1040–44.
Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(2):CD002096.
Sipponen P, Varis K, Fräki O, et al. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis: A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990;25(10):966–73.
Kwak H, Choi IJ, Cho S, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol 2014;29(9):1671–77.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424.
Yang L, Ying X, Liu S, et al. Gastric cancer: Epidemiology, risk factors and prevention strategies. Chin J Cancer Res 2020;32(6):695–704.
Teng AM, Blakely T, Baker MG, Sarfati D. The contribution of Helicobacter pylori to excess gastric cancer in Indigenous and Pacific men: a birth cohort estimate. Gastric Cancer 2017;20(4):752–55.
Zhao B, Zhang J, Mei D, et al. Does Helicobacter pylori eradication reduce the incidence of metachronous gastric cancer after curative endoscopic resection of early gastric cancer. J Clin Gastroenterol 2020;54(3):235–41.
Raderer M, Wöhrer S, Kiesewetter B, et al. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up. Ann Hematol 2015;94(6):969–73.
Kubovy J, Barclay ML. Helicobacter pylori in New Zealand: current diagnostic trends and related costs. N Z Med J 2022;135(1562):48–55.
Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr 2017;64(6):991–1003.
Bontems P, Kalach N, Vanderpas J, et al. Helicobacter pylori infection in European children with gastro-duodenal ulcers and erosions. Pediatr Infect Dis J 2013;32(12):1324–29.
Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev 2013;(12):CD008337.
Schubert JP, Gehlert J, Rayner CK, et al. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36(6):1450–56.
Ahmed D, Brooks H, McConnell M, Barbezat G. Antibiotic resistance in Helicobacter pylori: is it a problem in New Zealand? N Z Med J 2004;117(1200):U1022.
Yan L, Chen Y, Chen F, et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: Updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology 2022;163(1):154–62.e3

How to Treat

Paediatric eczema

Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management

Wednesday 14 August 2024, 12:45 AM